Skip to content

ACAD

ACADIA Pharmaceuticals Inc.

NASDAQ · USHealthcareBiotechnology
$25.09-1.99%

Price as of Jul 20, 2026

ACAD capital

ACADIA Pharmaceuticals Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.04x
Net debt / equity
-0.19x
Debt / assets
0.03x
Debt / EBITDA
0.40x
Net debt / EBITDA
-1.82x

Liquidity & coverage

Current ratio
3.59x
Quick ratio
3.48x
Cash ratio
2.79x
Interest coverage
EBITDA / interest
Working capital
$790.5M

Cash & dividend

FCF / debt
4.18x
Cash flow / debt
2.43x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.